America Great Health
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AAGH research report →
Companywww.americagreathealth.us
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and the manufacturing and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017.
- CEO
- Mike Qingkun Wang
- IPO
- 2012
- Employees
- 5
- HQ
- Alhambra, CA, US
Price Chart
Valuation
- Market Cap
- $2.12M
- P/E
- -3.67
- P/S
- 8.41
- P/B
- -0.37
- EV/EBITDA
- -15.57
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 83.59%
- Op Margin
- -124.03%
- Net Margin
- -228.85%
- ROE
- 10.24%
- ROIC
- 10.77%
Growth & Income
- Revenue
- $391.74K · 32.94%
- Net Income
- $-721,242 · 40.91%
- EPS
- $0.00 · 100.00%
- Op Income
- $-382,935
- FCF YoY
- 45.93%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 5.84
- Avg Volume
- 6.56M
Get TickerSpark's AI analysis on AAGH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AAGH Coverage
We haven't published any research on AAGH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AAGH Report →